Prevention of tumor growth by needle-free jet injection of anti-C7orf24 siRNA

Cancer Gene Therapy

Volumn 19, Issue 8, 2012, Pages 553-557

  Hama, S ^a   Arata, M ^a   Nakamura, I ^a   Kasetani, T ^a   Itakura, S ^a   Tsuchiya, H ^a   Yoshiki, T ^a   Kogure, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

C7orf24; cancer therapy; jet injection; siRNA

Indexed keywords

CHROMOSOME 7 OPEN READING FRAME 24 ANTIBODY SMALL INTERFERING RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CHROMOSOME 7; CHROMOSOME 7 OPEN READING FRAME 24; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; JET INJECTION; LUNG CANCER; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RNA INTERFERENCE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 7; GAMMA-GLUTAMYLCYCLOTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; HUMANS; INJECTIONS, JET; LUNG NEOPLASMS; MICE; NEOPLASM PROTEINS; OPEN READING FRAMES; RNA, SMALL INTERFERING;

MUS;

EID: 84864142412     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.31     Document Type: Article

References (28)

1. Kageyama S, Iwaki H, Inoue H, Isono T, Yuasa T, Nogawa M et al. A novel tumorrelated protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma. Proteomics Clin Appl 2007; 1: 192-199.
2. Zhang C, Li HR, Fan JB, Wang-Rodriguez J, Downs T, Fu XD et al. Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 2006; 7: 202.
3. Gromov P, Gromova I, Friis E, Timmermans-Wielenga V, Rank F, Simon R et al. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res 2010; 9: 3941-3953.
4. Uejima D, Nishijo K, Kajita Y, Ishibe T, Aoyama T, Kageyama S et al. Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma. Anticancer Res 2011; 31: 1297-1305.
5. Masuda Y, Maeda S, Watanabe A, Sano Y, Aiuchi T, Nakajo S et al. A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol. Biochem Biophys Res Commun 2006; 346: 454-460. (Pubitemid 43902707)
6. Juliano R, Alam MR, Dixit V, Kang H. Mechanisms and strategies for effective delivery of antisense and sirna oligonucleotides. Nucleic Acids Res 2008; 36: 4158-4171. (Pubitemid 351984831)
7. Shim MS, Kwon YJ. Efficient and targeted delivery of siRNA in vivo. FEBS J 2010; 277: 4814-4827.
8. Takei Y, Nemoto T, Mu P, Fujishima T, Ishimoto T, Hayakawa Y et al. In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency. Mol Cancer Ther 2008; 7: 211-221.
9. Kigasawa K, Kajimoto K, Hama S, Saito A, Kanamura K, Kogure K. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitislike model rat. Int J Pharm 2010; 383: 157-160.
10. Walther W, Stein U, Fichtner I, Malcherek L, Lemm M, Schlag PM. Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther 2001; 8: 173-180. (Pubitemid 32186128)
11. Walther W, Siegel R, Kobelt D, Knö sel T, Dietel M, Bembenek A et al. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer. Clin Cancer Res 2008; 14: 7545-7553.
12. Cartier R, Ren SV, Walther W, Stein U, Lewis A, Schlag PM et al. In vivo gene transfer by low-volume jet injection. Anal Biochem 2000; 282: 262-265. (Pubitemid 30439503)
13. Kogure K, Manabe S, Hama S, Tokumura A, Fukuzawa K. Potentiation of anticancer effect by intravenous administration of vesiculated alpha-tocopheryl hemisuccinate on mouse melanoma in vivo. Cancer Lett 2003; 192: 19-24. (Pubitemid 36287657)
14. Oakley AJ, Yamada T, Liu D, Coggan M, Clark AG, Board PG. The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle. J Biol Chem 2008; 283: 22031-22042.
15. Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011; 16: 123-140.
16. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 2008; 105: 13568-13573.
17. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008; 68: 1303-1309. (Pubitemid 351346836)
18. Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M et al. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther 2010; 9: 336-346.
19. Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 2010; 70: 5486-5496.
20. Shibata T, Saito S, Kokubu A, Suzuki T, Yamamoto M, Hirohashi S. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway. Cancer Res 2010; 70: 9095-9105.
21. Wakabayashi N, Shin S, Slocum SL, Agoston ES, Wakabayashi J, Kwak MK et al. Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Sci Signal 2010; 3: 52.
22. You A, Nam CW, Wakabayashi N, Yamamoto M, Kensler TW, Kwak MK. Transcription factor Nrf2 maintains the basal expression of Mdm2: an implication of the regulation of p53 signaling by Nrf2. Arch Biochem Biophys 2011; 507: 356-364.
23. Hansen JM, Watson WH, Jones DP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci 2004; 82: 308-317. (Pubitemid 39485343)
24. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000; 9: 165-169. (Pubitemid 30255378)
25. Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Günzel D, Fromm M et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 2005; 24: 1146-1156. (Pubitemid 40516598)
26. Grantab R, Sivananthan S, Tannock IF. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 2006; 66: 1033-1039. (Pubitemid 43165971)
27. Juliano R, Alam MR, Dixit V, Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 2008; 36: 4158-4171. (Pubitemid 351984831)
28. Kunugiza Y, Tomita N, Taniyama Y, Tomita T, Osako MK, Tamai K et al. Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with Shima Jet. Gene Ther 2006; 13: 1143-1152. (Pubitemid 44084073)